Universal Health assumed with a Neutral at Goldman Sachs

Goldman Sachs assumed coverage of Universal Health (UHS) with a Neutral rating and $219 price target The firm sees favorable trends continuing for the hospital sector through 2028, including supportive labor dynamics, tailwinds from previously approved pro-utilization government policies, and the industry showing more effective adaptation to structural changes. However, the sector will face new pressures from implementation of the One Big Beautiful Bill, the analyst tells investors in a research note.